
ChromoTek and NMI TT ally to start a new chapter in cellular high content analysis
ChromoTek GmbH (Martinsried, Germany) and NMI Technology Transfer GmbH (Reutlingen, Germany) have joined forces to advan…
ChromoTek GmbH (Martinsried, Germany) and NMI Technology Transfer GmbH (Reutlingen, Germany) have joined forces to advan…
Die ChromoTek GmbH (Martinsried) und die NMI Technologie Transfer GmbH (Reutlingen) bündeln ihre Kompetenzen, um ChromoT…
ChromoTek GmbH (Munich, Germany) has announced today the signing of a license agreement granting Bayer Pharma AG (Bayer)…
ChromoTek GmbH (Munich, Germany) offers nanobody based real time assays to visualize and measure the action of candidate…
Mona Chalabi aus Großbritannien hat die Jury mit ihrer Präsentation zur neuartigen Verwendung von GPS-Sensoren in der hu…
Chromotek GmbH (Munich, Germany) and Cell Culture Service GmbH (Hamburg, Germany) have entered into a service, distribut…
ChromoTek, a company specializing in bioimaging reagents, has launched the U2OS Cell Cycle Chromobody®, the first real-t…
High-Tech Gründerfonds and Bayern Kapital are investing about EUR 400k in Chromotek GmbH. The investment is intended to…
Der High-Tech Gründerfonds und Bayernkapital investieren rund 400 Tsd. Euro in die ChromoTek GmbH. Die Investition dient…
Die Bayerische Patentallianz GmbH vergibt im Auftrag der Ludwig-Maximilians-Universität (LMU) München Lizenzen über ein…